A new study published in the Canadian Medical Association Journal found that after medication policy measures were introduced at the beginning of the pandemic, the number of drug shortages dropped.
A U.S. federally funded systematic evidence review of 3,000 studies (25 of which had scientifically valid evidence) found that just three products showed evidence providing pain relief.
Health Canada first announced in 2019 that the Patented Medicine Prices Review Board would change how it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs by changing the countries Canada compares prices with.